Nutraceuticals: New Applications for Probiotics, Genetic Modification and Diet as Products Make Gains in Rx Territory

The nutraceuticals market is growing and diversifying rapidly. These products are linked by the fact that they are dietary products that have some degree of either purported or clinically evidenced medical benefit. However, the market lacks a clear definition of what constitutes a nutraceutical, with the term covering a spectrum of products from prescription-only medical foods to widely available consumer supplements. Recent research trends have demonstrated a wide array of potential applications for nutraceuticals, ranging from oncology to neurological and neurodevelopmental conditions. Much of the innovation in the field is being carried out by food companies, which are investing heavily in both early and applied R&D with well-defined and evidenced clinical applications, in a manner more typical of pharmaceutical companies. In contrast, pharmaceutical companies that are involved in this space typically manufacture consumer nutraceuticals. This report provides key industry perspective on the nutraceuticals industry from a large survey of over 150 food and pharmaceutical industry professionals, both within and outside of the nutraceuticals sector. Those involved in the industry were found to mostly believe in the value propositions of nutraceuticals, and expected their company to increase its level of investment in the area. In contrast, for those not involved with nutraceuticals the opposite was generally true. The industry survey showed a strong consensus that China, India and Brazil are the most promising geographies in terms of growth expectations for the nutraceuticals industry. This is partially due to the fact that the Western and Japanese markets, while are still expected to witness grow, are largely saturated, and partially due to the ability of nutraceuticals to treat a diverse array of indications at a low cost. Moreover, as GDP continues to rise in these economies, consumer nutraceuticals will be well positioned to capitalize on the growth in disposable income.

Scope

– How can the nutraceuticals sector be defined in general, and what types of product does it include?

– What are the key strategies used in marketing and developing some of the leading nutraceutical products?

– What are the key companies involved in nutraceuticals?

– What are some of the key upcoming products, companies and research trends within nutraceuticals?

– How does the regulatory landscape for different types of nutraceutical vary in key territories?

– What factors have hindered the growth of the nutraceuticals market?

– How can companies grow successfully within the nutraceuticals market?

Reasons to buy

- Understand the complex differences in the regional regulation of nutraceuticals, and how they shape the market

- Understand key future trends in the nutraceuticals market

- Gain an understanding of the industry perspective on critical aspects of the nutraceuticals industry, such as drivers, barriers, promising geographies and the value propositions of products

- Understand the strategies of key players from the food and pharmaceutical industries that are involved in the nutraceuticals market

Companies mentioned

Nestlé Health Sciences

Abbott Nutrition

Alfasigma USA

GlaxoSmithKline

Takeda

Danone

Table of Contents

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 4

1.2 List of Figures 4

2 Nutraceuticals Overview 5

2.1 An Unclear Definition of Nutraceuticals 5

2.2 Divide between Consumer-Oriented Products and Medical Foods 6

3 Key Nutraceutical Products - Case Studies 11

3.1 Souvenaid - Nutricia 11

3.2 Impact products - Nestlé Health Sciences 12

3.3 Deplin - Alfasigma 13

3.4 Vascepa - Amarin 14

3.5 Epanova - AstraZeneca 14

3.6 Meritene products - Nestlé Health Sciences 15

3.7 Pedialyte - Abbott 15

3.8 Tolerase L - DSM Nutritional Products 16

3.9 Armolipid Plus - Meda 17

4 Key Companies Involved in the Nutraceutical Market 18

4.1 Nestlé Health Sciences 18

4.2 Abbott Nutrition 20

4.3 Alfasigma USA 21

4.4 GlaxoSmithKline 21

4.5 Takeda 22

4.6 Danone 23

5 Regulatory Landscape and Promising Markets 25

5.1 The US: FDA (Food and Drug Administration) 25

5.1.1 Nutraceuticals as Drugs 25

5.1.2 Medical Foods 25

5.1.3 Foods for Special Dietary Use 26

5.1.4 Dietary Supplements 27

5.2 Europe 28

5.2.1 Supplements 28

5.2.2 Particular Nutritional Requirements of Specific Groups of the Populations (PARNUTS) Foods 29

5.2.3 Nutraceuticals Classified as General Foods 29

5.3 Japan 29

5.3.1 Food with Functional Nutrient Claims 30

5.3.2 Food for Special Dietary Uses 30

5.3.3 Foods for Specified Health Uses 30

5.4 Promising markets 31

6 Outlook for Nutraceuticals and Key Future Trends 32

6.1 Industry Sentiment and Growth Areas 32

6.2 Upcoming Companies- Case Studies 35

6.2.1 Biomeb: A company providing genetic and metabolic counseling and novel nutraceutical ingredients 35

6.3 Lycored: Successful despite failure to achieve regulatory clearance to list health benefits for key products 36

6.3.1 Cambridge Nutraceuticals: Experience of both sides of nutraceutical marketing regulations 36

6.4 The Microbiome and New Avenues for Nutraceuticals 37

6.5 Genetically Modified Organisms as Nutraceuticals 38

6.6 Barriers to Growth in the Nutraceutical Industry 39

6.7 Unclear Public Understanding of What Nutraceuticals Are 42

6.8 Reaching the Right Consumer Groups 42

6.9 Price 42

6.10 Perception of Nutraceuticals 42

6.11 Difficulty Proving Efficacy 43

6.12 Conclusion 43

7 Appendix 45

7.1 References 45

7.2 Abbreviations 47

7.3 Contact Us 48

7.4 Disclaimer 49

List of Tables

1.1 List of Tables

Table 1: Nutraceuticals Market, Global Product Profile; Souvenaid, 2017 12

Table 2: Nutraceuticals Market, Global Product Profile; Impact product range, 2017 13

Table 3: Nutraceuticals Market, Global Product Profile; Deplin, 2017 14

Table 4: Nutraceuticals Market, Global Product Profile; Vascepa, 2017 14

Table 5: Nutraceuticals Market, Global Product Profile; Epanova, 2017 15

Table 6: Nutraceuticals Market, Global Product Profile; Meritene, 2017 15

Table 7: Nutraceuticals Market, Global Product Profile; Pedialyte, 2017 16

Table 8: Nutraceuticals Market, Global Product Profile; Tolerase L, 2017 17

Table 9: Nutraceuticals Market, Global Product Profile; Armolipid plus, 2017 17

Table 10: Nutraceuticals Market, Global Company Product Profile; Alfasigma, 2017 21

Table 11: Nutraceuticals Market, Global Company Product Profile; Takeda, 2017 23

Table 12: Nutraceuticals Market, Global Company Profile; Danone, 2017 24

Table 13: Nutraceuticals Market, Medical foods Category Profile, 2017 26

Table 14: Nutraceuticals Market, The Distinction Between Medical Foods and Drugs, 2017 26

List of Figures

1.2 List of Figures

Figure 1: Perception of Public Understanding of the Definition of Nutraceuticals 5

Figure 2: Overall Industry Perception of Nutraceuticals 7

Figure 3: Industry Perception of Nutraceuticals by Region 8

Figure 4: Industry Perception of Nutraceuticals by Job Role 8

Figure 5: Industry Agreement with Nutraceuticals as Effective Adjuvants to Pharmacological Treatments 9

Figure 6: Nutraceutical Products, Categories and Classes from Consumer to Rx 9

Figure 7: Nestlé Acquisitions, Investments and Partnerships to 2017 20

Figure 8: Industry perception of key growth territories for nutraceuticals 31

Figure 9: Anticipated Company Investment in Nutraceuticals by 2020 32

Figure 10: Anticipated Investment in Nutraceuticals by 2020 by Sector and job role 33

Figure 11: Industry consensus of important growth promoting factors 33

Figure 12: Industry consensus of important growth promoting factors by region 34

Figure 13: Industry consensus of important growth promoting factors by job role 34

Figure 14: Industry Perception of the Extent to Which Nutraceuticals will Compete with Mainstream Pharmaceuticals 39

Figure 15: Industry consensus on limiting factors for nutraceutical growth 40

Figure 16: Industry consensus on limiting factors for nutraceutical growth by region 41

Figure 17: Industry consensus on limiting factors for nutraceutical growth by job role 41

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports